Abstract In 2011, the European Society for the Study of Tourette Syndrome (ESSTS)
published the first European guidelines for Tourette Syndrome (TS). We now present an …

Introduction Tourette syndrome (TS) is a childhood-onset neurobehavioral disorder
characterized by tics. Pharmacotherapy is advised for patients whose symptoms affect their …

Abstract Background Attention Deficit Hyperactivity Disorder (ADHD) is the most common co-
morbid condition encountered in people with tics and Tourette Syndrome (TS). The co …

Introduction Stimulants, including methylphenidate and amphetamines, are the first-line
pharmacological treatment of ADHD in adults. However, in patients who do not respond or …

Gilles de la Tourette Syndrome (GTS) is characterized by motor and vocal tics, as well as
associated comorbid conditions including obsessive-compulsive disorder (OCD), attention …

Tourette's syndrome (TS) is a neuropsychiatric disorder of childhood onset characterized by
multiple motor and phonic tics that fluctuate over time. Tic symptoms often improve by late …

Abstract Background Both the US FDA and the European Medicines Agency (EMA) have
approved aripiprazole for use in adolescents for specific indications. Given the assumed …

Background Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder
(ADHD) are frequently overlap** neurodevelopmental disorders. Individuals in whom the …

ABSTRACT Introduction Neurodevelopmental disorders (NDDs) are a group of complex and
heterogeneous disorders, caused by the disruption of normal brain development …

Tourette syndrome is a childhood onset neurodevelopmental disorder characterized by
multiple motor and vocal tics. Although many youth experience attenuation or even …